Tested product | Patient | Predominant bacterial species isolated from milk sample | CFU/mL | SCC/mL |
---|---|---|---|---|
Group 1 treated with R4 | 1. | 902,000 | 169,800 | |
2. | 385,000 | 1,000,000 | ||
3. | 89,000 | 114,300 | ||
4. | 49,000 | 190,800 | ||
5. | 172,000 | 3,600 | ||
6. | 312,000 | 51,900 | ||
7. | 171,600 | 195,800 | ||
8. | 364,000 | 240,000 | ||
Group 2 treated with R7 | 9. | 66,000 | 102,100 | |
10. | 334,000 | 80,300 | ||
11. | 125,000 | 39,000 | ||
12. | 41,000 | 54,000 | ||
13. | 48,000 | 105,900 | ||
14. | 37,000 | 10 000 | ||
15. | 177,000 | 129,000 | ||
16. | 247,900 | 1,000,000 | ||
Control group treated with antibiotics | 17. | 223,000 | 10,000 | |
18. | 525,000 | 1,004,600 | ||
19. | 218,000 | 12,000 | ||
20. | 220,000 | 88,900 |
Identified microorganism | Gram +/− | Kit type | Code profile |
---|---|---|---|
+ | API Staph | 6 7 7 3 1 5 1 | |
+ | API Staph | ATCC 6538P | |
+ | API Staph | 6 7 3 2 5 5 3 | |
+ | API Staph | 6 7 3 2 1 1 2 | |
+ | VITEK Identification | 0625703821500211 | |
+ | VITEK Identification | 0625707930700413 | |
+ | VITEK Identification | 0209610546712053 | |
+ | API 50 CHB | 7212 | |
+ | VITEK Identification | 4407611554521210 | |
+ | VITEK Identification | 0625703050500211 | |
+ | VITEK Identification | 0205610554226611 |